These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25408230)

  • 1. Lessons learned from the clinical development of oral peptides.
    Karsdal MA; Riis BJ; Mehta N; Stern W; Arbit E; Christiansen C; Henriksen K
    Br J Clin Pharmacol; 2015 May; 79(5):720-32. PubMed ID: 25408230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.
    Karsdal MA; Henriksen K; Bay-Jensen AC; Molloy B; Arnold M; John MR; Byrjalsen I; Azria M; Riis BJ; Qvist P; Christiansen C
    J Clin Pharmacol; 2011 Apr; 51(4):460-71. PubMed ID: 20660294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.
    Henriksen K; Andersen JR; Riis BJ; Mehta N; Tavakkol R; Alexandersen P; Byrjalsen I; Valter I; Nedergaard BS; Teglbjaerg CS; Stern W; Sturmer A; Mitta S; Nino AJ; Fitzpatrick LA; Christiansen C; Karsdal MA
    Bone; 2013 Mar; 53(1):160-6. PubMed ID: 23234813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral recombinant human parathyroid hormone [rhPTH(1-31)NH₂] in postmenopausal women with osteoporosis.
    Sturmer A; Mehta N; Giacchi J; Cagatay T; Tavakkol R; Mitta S; Fitzpatrick L; Wald J; Trang J; Stern W
    Clin Pharmacokinet; 2013 Nov; 52(11):995-1004. PubMed ID: 23719683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration strategies for proteins and peptides.
    Ibraheem D; Elaissari A; Fessi H
    Int J Pharm; 2014 Dec; 477(1-2):578-89. PubMed ID: 25445533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral protein delivery: a patent review of academic and industrial approaches.
    Werle M; Makhlof A; Takeuchi H
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):94-104. PubMed ID: 19519570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.
    Drucker DJ
    Curr Pharm Des; 2001 Sep; 7(14):1399-412. PubMed ID: 11472275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery.
    Chen SC; Eiting K; Cui K; Leonard AK; Morris D; Li CY; Farber K; Sileno AP; Houston ME; Johnson PH; Quay SC; Costantino HR
    J Pharm Sci; 2006 Jun; 95(6):1364-71. PubMed ID: 16625659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems.
    Okeyo PO; Rajendran ST; Zór K; Boisen A
    Adv Drug Deliv Rev; 2021 Sep; 176():113850. PubMed ID: 34182015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melt extrusion: process to product.
    Repka MA; Shah S; Lu J; Maddineni S; Morott J; Patwardhan K; Mohammed NN
    Expert Opin Drug Deliv; 2012 Jan; 9(1):105-25. PubMed ID: 22145932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles.
    Lv BH; Tan W; Zhu CC; Shang X; Zhang L
    Med Sci Monit; 2018 Oct; 24():7532-7540. PubMed ID: 30345994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
    Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C
    Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based oral peptide nanomedicines.
    Herrero EP; Alonso MJ; Csaba N
    Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi.
    Heavey MK; Anselmo AC
    AAPS J; 2021 May; 23(4):76. PubMed ID: 34009532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
    van der Merwe SM; Verhoef JC; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Jan; 57(1):85-91. PubMed ID: 14729083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in oral delivery of peptide hormones.
    Varamini P; Toth I
    Expert Opin Drug Deliv; 2016; 13(4):507-22. PubMed ID: 26787260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
    Slomkowski S; Gosecki M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.